CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
Stopped Study was split into two new studies before the first participant was enrolled.
Conditions
- Hematologic Diseases
- Hematologic Malignancy
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Myelogenous Leukemia
- Chronic Lymphocytic Leukemia
Interventions
- DEVICE: CliniMACS
- PROCEDURE: Bone Marrow Transplant
- DRUG: Hyperfractionated Total Body Irradiation
- DRUG: Thiotepa
- DRUG: Cyclophosphamide
- DRUG: Busulfan
- DRUG: Melphalan
- DRUG: Fludarabine
Sponsor
Baptist Health South Florida